Our Technology
—
Innovative technology is transforming disease detection. By leveraging DNA methylation as our core approach, we offer simple and accessible early cancer detection, making precision medicine more widely available and convenient.
Core Technology
DNA methylation testing involves analyzing changes in DNA methylation patterns to gain insights into your health. Research has shown that cancer cells exhibit specific gene methylation changes at early stages, which can serve as significant markers for cancer.
When cancer cells die or undergo necrosis, these unique cancer cell DNA methylation patterns are released into the bloodstream. By simply drawing 8 milliliters of blood and extracting the circulating DNA, methylation analysis can reveal abnormal conditions in certain tissues, providing a fast and precise evaluation of your health status.
Versatile Applications
By analyzing DNA methylation patterns, we can detect cancer risks early, offering critical insights at the initial disease stages. This allows patients to undergo professional evaluation and diagnosis before symptoms become apparent, increasing treatment options and improving recovery rates. Early intervention not only reduces disease progression risks but also significantly enhances quality of life and survival outcomes.
DNA methylation does not alter the genetic sequence but is influenced by factors such as lifestyle, diet, stress, and the environment. Studies suggest that abnormal methylation may suppress tumor-fighting genes or activate cancer-causing genes, raising the risk of cancer.
Early Detection
With DNA methylation analysis, we can identify cancer risks at an early stage, providing essential clues before symptoms appear. This enables timely medical intervention, improving treatment effectiveness and survival rates. Currently, many cancers are diagnosed at advanced stages due to the lack of effective early screening tools. Our technology fills this critical gap, offering a powerful solution for earlier cancer detection and better patient outcomes.
Most cancers are diagnosed at a late stage due to the lack of effective early screening tools. By analyzing DNA methylation changes, we can detect cancer risks earlier, leading to improved treatment outcomes and higher survival rates.